MYC and melanoma: In clinical studies of gastric cancer (GC), NSCLC, and melanoma[47], elevated expression of glycolysis-related molecules lactate dehydrogenase A and oncogene c-Myc (MYC) correlated with resistance to PD-1 blockade.